Warp: I thought the "Pilot Study" was completed a
Post# of 30028
Posted On: 07/15/2014 3:05:40 PM
Warp: I thought the "Pilot Study" was completed a few months ago. Today's PR referred to a "bridge study" they were just now conducting and which he says was formerly referred to as the "Pilot Study." This "Bridge Study" is comparing version 1 with version 2 of LymPro. He says they hope to reveal the "top line results" of this study in two weeks. Have you ever heard of this until today? You weren't surprised by this today? It sounds new to me.
Copenhagen was to be the showcase of our impressive LymPro data to the AD community. But truthfully, as closely as I've followed LymPro, and even though I have a College Degree, all the different changing test names it has been going through is all mush to me.
I can't positively tell you what tests we presented in the posters and which tests we'll present in two weeks. It is anything but straight forward! I'm not an idiot, I am capable of understanding things. But I really can't explain very well what Amarantus has been doing with LymPro over the past year! It should be easy to list each test, it's name, it's results, and there, you have it. But they haven't made it that straight forward.
Warp: Can you lay out the 3 or 4 or 5 tests they've done on LymPro for me? I'd love to know the name of each test, how many patients were studied, and what the results were of each test. I'm not really sure what we presented yesterday. Was it the pilot study we did in the first quarter this year, or was it a part of the validation BD did last year? I know we presented the 7 year study today. It's unclear.
And this new "Bridge Study" is totally new. Instead of getting LymPro's big results in Copenhagen, we were told of a new test that won't even be completed by the Summit. I think we all would like more transparency and clarity about an issue so important to us.
Copenhagen was to be the showcase of our impressive LymPro data to the AD community. But truthfully, as closely as I've followed LymPro, and even though I have a College Degree, all the different changing test names it has been going through is all mush to me.
I can't positively tell you what tests we presented in the posters and which tests we'll present in two weeks. It is anything but straight forward! I'm not an idiot, I am capable of understanding things. But I really can't explain very well what Amarantus has been doing with LymPro over the past year! It should be easy to list each test, it's name, it's results, and there, you have it. But they haven't made it that straight forward.
Warp: Can you lay out the 3 or 4 or 5 tests they've done on LymPro for me? I'd love to know the name of each test, how many patients were studied, and what the results were of each test. I'm not really sure what we presented yesterday. Was it the pilot study we did in the first quarter this year, or was it a part of the validation BD did last year? I know we presented the 7 year study today. It's unclear.
And this new "Bridge Study" is totally new. Instead of getting LymPro's big results in Copenhagen, we were told of a new test that won't even be completed by the Summit. I think we all would like more transparency and clarity about an issue so important to us.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼